| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
TECH sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 170.2K | $12.32M | - | |
| CEO | 82.8K | - | - | |
| Dir | 77.3K | - | - | |
| Dir | 56.9K | - | - | |
| Pres | 24.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2023 | Nusse Roeland51 | Director | Sale+OE | 8,939 | $80.32 | $717,959.03 | -14.7% | -23.2% | -7.1% | |
| Jul 21, 2023 | Kummeth Charles R.77 | Chief Executive Officer | Sell10b5-1 | 80,000 | $88.36 | $7,069,024.00 | -6.0% | -29.0% | -15.6% | |
| Jun 7, 2023 | Kummeth Charles R.77 | Chief Executive Officer | Sell | 322 | $83.00 | $26,726.00 | - | -6.1% | -4.2% | |
| Dec 8, 2022 | Furlow Brenda S.70 | SVP - General Counsel | Sale+OE | 8,250 | $82.11 | $677,415.43 | -24.0% | -9.0% | -16.6% | |
| Aug 11, 2022 | Higgins John L66 | Director | Sale+OE | 2,504 | $378.80 | $948,516.15 | -31.3% | -16.3% | -9.7% | |
| Jun 8, 2022 | Higgins John L66 | Director | Sale+OE | 1,600 | $364.98 | $583,964.00 | -25.8% | -9.6% | -12.8% | |
| Jun 7, 2022 | Kummeth Charles R.77 | Chief Executive Officer | Sale+OE | 5,104 | $365.00 | $1,862,960.00 | -2.5% | -10.0% | -9.9% | |
| May 10, 2022 | Baumgartner Robert V45 | Director | Buy | 300 | $352.55 | $105,765.00 | +3.1% | +6.8% | -7.3% | |
| Nov 19, 2021 | Kelderman Kim67 | President Diagnostics &Genom | Sale+OE | 500 | $505.38 | $252,689.00 | - | -20.5% | -34.2% | |
| Nov 12, 2021 | Eansor Norman David52 | President-protein Sciences | Sale+OE | 27,159 | $504.00 | $13,688,192.94 | -95.4% | -16.1% | -30.4% |